- PVLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Palvella Therapeutics (PVLA) 10-K/A2015 FY Annual report (amended)
Filed: 20 Jul 16, 12:00am
Exhibit 31.5
CERTIFICATIONS UNDER SECTION 302
I, Stephen S. Yoder, certify that:
1. I have reviewed this Amendment No. 2 on Form 10-K/A of Pieris Pharmaceuticals, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: July 20, 2016
/s/ Stephen S. Yoder |
Stephen S. Yoder |
Title: Chief Executive Officer and President (principal executive officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.